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Background: It has been widely recognized that small RNAs (sRNAs) play important roles in physiology and
virulence control in bacteria. In Staphylococcus aureus, many sRNAs have been identified and some of them have
been functionally studied. Since it is difficult to identify RNA-binding proteins (RBPs), very little has been known
about the RBPs in S. aureus, especially those associated with sRNAs.
Results: Here we adopted a tRNA scaffold streptavidin aptamer based pull-down assay to identify RBPs in S. aureus.
The tethered RNA was successfully captured by the streptavidin magnetic beads, and proteins binding to RNAIII
were isolated and analyzed by mass spectrometry. We have identified 81 proteins, and expressed heterologously
9 of them in Escherichia coli. The binding ability of the recombinant proteins with RNAIII was further analyzed by
electrophoresis mobility shift assay, and the result indicates that proteins CshA, RNase J2, Era, Hu, WalR, Pyk, and
FtsZ can bind to RNAIII.
Conclusions: This study suggests that some proteins can bind to RNA III in S. aureus, and may be involved in RNA
III function. And tRSA based pull-down assay is an effective method to search for RBPs in bacteria, which should
facilitate the identification and functional study of RBPs in diverse bacterial species.
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Staphylococcus aureus is a human and animal pathogen
that can cause multiple infectious diseases. The high
infection ability of the bacterium depends on the produc-
tion of many virulence factors, which are under control of
multiple regulatory pathways. These regulators include
transcriptional regulator proteins, two-component systems,
and small RNAs (sRNAs).
sRNAs in bacteria range from 50 to several hundred
nucleotides, and function through RNA-RNA base
pairing to activate or block the translation, or to induce the
degradation of target mRNA. RNAIII is a 514 nucleotides
sRNA, and can regulate the expression of many virulence
genes as well as some regulators at the post-transcriptional* Correspondence: xuet@ahau.edu.cn; sunb@ustc.edu.cn
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unless otherwise stated.level. Binding between RNAIII and its targets can lead to
translation activation, translation blocking, or mRNA
degradation mediated by RNase III [1].
Nowadays, hundreds of sRNAs have been identified
in S. aureus, but very little has been known about
RNA-binding proteins (RBPs) involved in sRNA regulation
in this bacterium. It has been widely recognized that Hfq
acts as an important chaperone in many Gram-negative
bacteria [2]. In S. aureus, Hfq can bind to specific short
RNA [3, 4], but deletion of hfq has no significant impact
on sRNA stability or regulation, suggesting that Hfq is not
an RNA chaperone in S. aureus [5]. RNase III is the only
ribonuclease proved to be important for sRNA regulation
in S. aureus, and it degrades double-stranded RNA formed
by base-pairing of RNAIII with its mRNA targets such as
spa, coa, and rot [6]. sRNA regulation may involve some
other ribonucleases, which have not been studied yet.
Besides, a transcriptional regulator SarA may act as an
RBP and affect mRNA stability [7]. Thus, it is appealing toThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Fig. 1 Procedure of the pull-down assay. a Composition of the pull-down system. RNAIII was attached to the 3′-end of the tRSA, and the
SA-PMPs was used to capture the aptamer. b The tethered RNA was used for pull-down assay and the captured RNA in each step was collected
and qualified by real-time RT-PCR. The RNA abundance of input sample was indicated as 1,000. c The integrity of the RNA collected in each step
was assayed by electrophoresis. The input sample was diluted 100 times and the pull-down sample was diluted 10 times. RNA sample (10 μl)
was loaded to the electrophoresis. d Proteins retained on the beads were analyzed by silver staining. Protein sample (10 μl) was applied to 12 %
PAGE and then silver staining
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S. aureus [1, 8].
RBPs are difficult to identify due to the lack of effective
tags. In previous studies, RNA affinity chromatography was
used to purify a c-myc binding protein [9]; biotin labelingFig. 2 Classification of the proteins binding to RNAIII. a The proteins identifie
Groups) data in NCBI. The proteins from S. aureus strain NCTC8325 was applie
the same way. b The conserved domains in the identified proteins were genewas used for affinity purification of many RBPs [10–12];
and in recent years, some RNA aptamers have been
developed to bind to specific molecules and can be used as
affinity tags, including aptamers binding to MS2 protein
[13], tobramycin [14], sephadex [15], streptomycin [16],d by LC-MS were classified based on the COG (Cluster of Orthologous
d to LC-MS and the components of each class of proteins were analyzed
ralized based on the Uniprot database
Table 1 List of the proteins with RNA-binding and
DNA-binding domains identified by MS
Proteins with RNA-binding domains
Gene Protein
SAOUHSC_00769 Protein translocase subunit SecA
SAOUHSC_01035 Ribonuclease J 1
SAOUHSC_01252 Ribonuclease J 2
SAOUHSC_01659 Putative uncharacterized protein
SAOUHSC_01679 Putative uncharacterized protein
SAOUHSC_01207 Signal recognition particle protein
SAOUHSC_01184 Sun protein
SAOUHSC_02362 Transcription termination factor Rho
SAOUHSC_01492 GTP-binding protein EngA
SAOUHSC_01163 Pseudouridine synthase
SAOUHSC_01668 GTP-binding protein Era
SAOUHSC_00464 Ribosomal RNA small subunit methyltransferase A
SAOUHSC_01203 Ribonuclease III
SAOUHSC_00513 Putative uncharacterized protein
SAOUHSC_02303 mRNA interferase MazF
Proteins with DNA-binding domains
Gene Protein
SAOUHSC_01099 Endonuclease MutS2
SAOUHSC_01351 DNA topoisomerase 4 subunit B
SAOUHSC_00001 Chromosomal replication initiator protein DnaA
SAOUHSC_01682 Chaperone protein DnaJ
SAOUHSC_01850 Catabolite control protein A
SAOUHSC_01576 Exonuclease family protein
SAOUHSC_01454 Putative uncharacterized protein
SAOUHSC_00467 Pur operon repressor
SAOUHSC_00020 Transcriptional regulatory protein WalR
SAOUHSC_01490 DNA-binding protein Hu
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more stable, tRNA scaffold was developed [18], and then
tRNA scaffold to a streptavidin aptamer (tRSA) was suc-
cessfully invented as an affinity matrix, which can efficiently
capture some transcript-specific RBPs from cell lysates [19].
Aiming to identify proteins binding to RNAIII, we carried
out pull-down assay using tRSA as a tag in this study. The
tethered RNAs were successfully captured by Streptavidin
MagneSphere Paramagnetic Particles (SA-PMPs), and those
proteins binding to RNAIII were isolated and analyzed by
mass spectrometry (MS). Using this method, 81 proteins
were identified, and RNA-binding abilities of 9 proteins
were further determined by electrophoresis mobility shift
assay (EMSA). Our data indicate that some proteins can
bind to RNAIII, and that tRSA based pull-down assay is an
effective method to identify RBPs in S. aureus. Further
research on these RBPs should shed light on the function
and mechanisms of sRNA regulation in S. aureus.
Results
tRSA-RNAIII and the RBPs were captured by SA-PMPs
in the pull-down system
Aiming to identify RNAIII-binding proteins, we performed
the pull-down assay using tRSA as a tag. Streptavidin
aptamer fusion in the anti-code site of tRNA was captured
by streptavidin PMPs, while RNAIII attached to the 3′ site
of tRNA can act as a bait for RBPs (Fig. 1A). About 0.3 μg
RNA was captured by the SA-PMPs in the pull-down
process (Fig. 1B). Although a lot of RNA was degraded, the
RNA captured was intact (Fig. 1C), which can act as the
bait RNA for protein binding. Proteins retained on the
beads were analyzed by silver staining, with proteins
binding to empty SA-PMPs as negative controls (Fig. 1D,
lane NC), and the major bands were identified by LC/MS
(Additional file 1: Table S1). From three biologically
independent experiments, 81 proteins were identified and
quantified from at least two replicates.
Classification of the proteins binding to RNAIII
The identified proteins were divided into different classifica-
tions based on the COG (Cluster of Orthologous Groups)
data in NCBI. The percentage of most kinds of proteins in
the pull-down sample was similar to that in the S. aureus
NCTC8325 proteomics. In contrast, cell wall/membrane
biogenesis proteins (15 and 2 in pull down sample and
NCTC8325, respectively) and replication-, recombination-
and repair-related proteins (5 and 2 in pull-down sample
and NCTC8325, respectively) were enriched in the RNAIII
pull-down system (Fig. 2A), suggesting that these two kinds
of proteins may have higher affinity to RNAIII. These pro-
teins were then classified by the conserved domain analysis.
In these 81 proteins, only 18.5 % were predicted to
have RNA-binding domains, while 12.5 % contain DNA-
binding domains and the others were not known to haverelationships with RNA or DNA (Fig. 2B). Those proteins
with RNA/DNA-binding motifs were listed in Table 1.
Confirmation of the binding ability of the protein
candidates
Those protein candidates with RNA or DNA-binding
domains have more possibility to interact with RNA
because of the structural similarity between RNA and
DNA, while the interactions between RNA and other
proteins need to be further verified. To confirm that the
protein candidates identified were RBPs, the binding
ability of these proteins was validated by EMSA. Eleven
recombinant proteins with different kind of motifs
were expressed in E. coli, including four proteins with
RNA-binding motifs, two proteins with DNA-binding
motifs, and three proteins with no nucleic acid-binding
motif. PNPase and Enolase were suggested to be the
Zhang et al. BMC Microbiology  (2015) 15:102 Page 4 of 8components of RNA degradosome, but they were not
found in our pull-down assay (Fig. 3A).
RNase III has an RNA-binding motif, and exhibited
RNA degradation activity (Fig. 3B), which is consistent
with the previous report [20]. CshA, RNase J2, and Era
also have RNA-binding motifs and showed binding ability
with RNAIII (Fig. 3B). Hu and WalR have DNA-binding
domain, and also showed RNAIII binding ability (Fig. 3C).
Surprisingly, Pyk and FtsZ, without RNA/DNA-binding
domains, also had binding activity with RNAIII. PfkA did
not bind to RNAIII even at high concentration (Fig. 3C).
As expected, PNPase and Enolase did not bind to RNAIII
(Fig. 3D), which was consistent with the pull-downFig. 3 Expression and EMSA of the binding ability of the protein candidate
details are listed in Tables 2, 3 and 4. b, c, and d The binding ability of pro
(0.24 μM) were used in all reactions. Increasing amounts of different protein
proteins containing RNA-binding motifs (RNase III 0, 2, 4, 8 μM; CshA 0, 6.5, 32
proteins containing DNA-binding motifs, and three proteins unrelated to nuc
27, 140 nM; pfkA 0, 16, 140 μM). Figure (d) represents two negative control prassay results. Among the nine proteins identified, eight
can interact with RNAIII, suggesting that our pull-down
and MS assays are effective and reliable.
Discussion
The significance of sRNA in gene regulation in bacteria
is now widely recognized [1, 21], and more bacterial
sRNAs have been identified in the last decade [22, 23].
In S. aureus, hundreds of sRNAs have been identified,
and some of them have been proved to play roles in
physiology and virulence control [24]. The sRNA-mRNA
base-pairing mechanism has been found ubiquitously in
sRNA regulation in S. aureus, whereas, there is currentlys. a Protein candidates expressed in E. coli. The clone and expression
teins to RNAIII was determined by EMSA. DIG-labeled RNAIII probes
s were incubated with labeled RNAIII probes. Figure (b) represents four
μM; RNase J2 0, 3.2, 6.4 μM; Era 0, 2.9, 5.8 μM.), Figure (c) represents two
leic acid (Hu 0, 180, 360 μM; WalR 0, 75, 150 μM; Pyk 0, 6.3, 13 μM; FtsZ 0,
oteins (PNPase 0, 1.3, 12 μM; Enolase 0, 2.1, 19 μM)
Table 2 Bacteria strains and plasmids used in this study
Strain or plasmid Comments Source or Reference
Strains
S. aureus NCTC8325 Wild type NARSAa
E. coli DH5α Clone host strain Laboratory stock
E. coli BL21 (DE3) Expression host strain Laboratory stock
E. coli M15 (pREP4) Expression host strain Laboratory stock
Plasmids
pcDNA3-tRSA Template for tRSA [19]
pEASY TB Clone vector, Kanr Apr Transgen
pSXZ06 pEASY TB with RNAIII for
in vitro transcription
[36]
pET28a (+) Expression vector with
hexahistidine tag, Kanr
Novagen
pET21b (+) Expression vector with
hexahistidine tag, Apr
Novagen
pQE30 Expression vector with
hexahistidine tag, Apr
QIAGEN
pQE30-RNase III Expression vector for
protein RNase III
[36]
pET28a-Hu Expression vector for
protein Hu
This study
pET21b-FtsZ Expression vector for
protein FtsZ
This study
pET28a-Pyk Expression vector for
protein Pyk
This study
pET28a-Era Expression vector for
protein Era
This study
pET28a-WalR Expression vector for
protein WalR
[37]
pET22b-RNase J2 Expression vector for
protein RNase J2
This study
pET22b-CshA Expression vector for
protein CshA
This study
pET22b-PNPase Expression vector for
protein PNPase
This study
pET22b-PfkA Expression vector for
protein PfkA
This study
pET24a-Enolase Expression vector for
protein Enolase
This study
a NARSA, Network on Antimicrobial Resistance in Staphylococcus aureus
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might be involved in sRNA regulation [1]. RNase III
[20], Hfq [8, 25], and the transcriptional regulator
SarA [26] are those only RBPs known in S. arueus.
RBPs involved in sRNA regulation may include RNA
chaperones, RNA helicases, ribonucleases, and some
regulators [8]. Also, the activity of some enzymes may
be affected by RNA binding [27]. Identification of RBPs in
S. arueus in this study may help us better understand the
details about sRNA regulation in staphylococci and other
bacterial pothogens.tRSA is an efficient RNA aptamer tag for RNA pull-
down assay [19, 28, 29]. After invented, tRSA has already
been used in different kinds of researches, including
microRNA-RNA interaction [28], co-expression of
RNA/protein complex, and isolation of RBPs [30]. This
RNA aptamer does not need recombinant proteins or
affinity matrices compared to those MS2 aptamers; and
the labeling is easier and cheaper than biotin. Because
there are some standardized reagents for this tag, the
effect and stability of the experiment system may be
improved a lot. In this study, we used the streptavidin
magnetic beads to capture the tRSA tag. Using this
system, we have successfully identified proteins binding to
RNAIII in S. aureus, and this technique may be well
suitable for the identification of RBPs in other bacteria.
The proteins captured by RNAIII in our study include
various kinds of proteins, some of which have been
reported to participate in RNAIII function. RNase III can
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RNAIII with its mRNA targets [1], and it also can digest
RNAIII [20]. Era was known to consist of a K homology
domain and to recognize the sequence of 16S rRNA of S.
aureus [31], and we show here it can also bind to RNAIII
in vitro. It was reported that eight proteins (CshA, RNase
J1, RNase J2, RNase Y, PNPase, Enolase, PfkA and RnpA)
may interact with S. aureus RNA degradosome, which has
been confirmed by bacterial two-hybrid analysis [32]. We
here show that CshA and RNase J2 can bind to RNAIII,
while PNPase and Enolase cannot. CshA was reported to
be involved in mRNA half-life control in S. aureus [33],
and it may also influence the stability of RNAIII. Besides,
we have identified some DNA-binding proteins that can
bind to RNAIII, including Hu, which has already been
proved to bind to rRNA, tRNA segments, and a few small
RNAs related to nucleoid morphology in E. coli [34];
WalR is a transcriptional factor involved in autolysis,
biofilm formation, and cell wall metabolism. Our results
show that WalR can bind to RNAIII as well, which may
have the same property as the transcriptional factor SarA
[26]. We further show that some metabolism-related pro-
teins can bind to RNAIII, including pyruvate kinase and
FtsZ, and this should provide us a new perspective about
sRNA-mediated metabolism control.
Another concern in the interaction between RNA and
RBPs is the binding specificity. RBPs may recognize
specific sequences or structures in their RNA targets
[35]. Some of the proteins we identified may bind not
only to RNAIII, but also to other RNA or DNA. Further
study may illustrate the RNA binding specificity of these
RBPs and the relating molecular mechanisms.
Conclusions
Pull-down assay using tRNA scaffold streptavidin aptamer
was performed to search for the proteins binding to
RNAIII in S. aureus. By using this method, 81 proteins
binding to RNAIII were identified by the pull-down andTable 4 Conditions used for protein expression
Name OD600 IPTG Temperature
RNase III 0.2 1 mM 30 °C for 4 h
Hu 0.8 1 mM 16 °C for 16 h
FtsZ 0.6 0.5 mM 20 °C for 16 h
Pyk 0.6 0.2 mM 30 °C for 5 h
Era 0.6 0.5 mM 16 °C for 16 h
WalR 0.6 0.5 mM 20 °C for 16 h
RNase J2 0.6 0.4 mM 16 °C for 20 h
CshA 0.6 0.4 mM 16 °C for 20 h
PNPase 0.6 0.4 mM 16 °C for 20 h
PfkA 0.6 0.4 mM 16 °C for 20 h
Enolase 0.6 0.4 mM 16 °C for 20 hMS assay, and the binding ability of 9 proteins with
RNAIII was verified by EMSA. Proteins CshA, RNase J2,
Era, Hu, WalR, Pyk and FtsZ were confirmed to bind to
RNAIII. The finding and investigation of proteins binding
to RNAIII should facilitate sRNA study in staphylococci.
Methods
Strains and plasmids
Strains and plasmids used in this study are listed in Table 2.
E. coli strains were grown at 37 °C in Luria-Bertani (LB)
medium with suitable antibiotics: ampicillin (100 μg/mL)
or kanamycin (50 μg/mL). S. aureus strains were grown at
37 °C in tryptic soy broth (TSB, Oxiod). The media were
solidified with 1.5 % (wt/vol) agar as needed.
In vitro RNA synthesis
The template for tRSA-RNAIII transcription was digested
from plasmid pSXZ06. The RNAs were produced by
in vitro transcription as described [36], using a RiboMAX
Large Scale RNA Production Systems-T7 (Promega). RNAs
were labeled with DIG using RNA labeling Mix (Roche).
RNA isolation and real-time RT-PCR
RNA was extracted using the Trizol method (Invitrogen),
and residual DNA was digested with 10 U of DNaseI
(Takara) at 37 °C for 1 h. Reverse transcription was carried
out with the PrimeScript 1st Strand cDNA synthesis kit
(Takara) and real-time PCR was performed with SYBR
Premix Ex Taq (TaKaRa) using a StepOne real-time
system (Applied Biosystems). The RNA abundance of
input sample was indicated as 1,000 and the relevant
quantification of captured RNA was analyzed by calculat-
ing the difference of CT in the real-time PCR.
RBPs pull-down assay
RBPs pull-down assay was performed as previously
described [19], with some modifications. Briefly, S. aureus
cultures (2 ml) were collected and bacterial cells wereBuffer
30 mM Tris–HCl, 500 mM KCl, 0.1 mM DTT, 0.1 mM EDTA, pH 8.0
50 mM PBS, 150 mM NaCl, pH 7.8
50 mM Tris–HCl, 300 mM NaCl, pH 8.0
30 mM Tris–HCl, 200 mM NaCl, pH 7.8
50 mM Tris–HCl, 500 mM NaCl, pH 8.0
50 mM Tris–HCl, 200 mM NaCl, pH 8.0
20 mM Tris–HCl, 200 mM NaCl, pH 7.5
20 mM Tris–HCl, 1 M NaCl, pH 7.5
20 mM Tris–HCl, 200 mM NaCl, pH 7.5
20 mM Tris–HCl, 200 mM NaCl, pH 7.5
20 mM Tris–HCl, 200 mM NaCl, pH 7.5
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200 mM NaCl, 1 % Triton X-100, 10 mM MgCl2, 1 mM
DTT) containing protease inhibitor cocktail (Sangon),
and 40 U/ml lysostaphin (AMBI). The suspension was
incubated at 37 °C for 10 min to lyse the cell. After
centrifugation at 12,000 g for 30 min, the supernatants
were collected and the concentration of total protein was
quantified by BCA assay. Avidin (Calbiochem, 10 mg/mg
protein), Yeast RNA (Sigma, 0.5 mg/mg protein), and
RNase inhibitor (3 μl, Transgen) were added as the final
pre-cleared lysates. About 2 mg protein was applied for
each pull-down assay.
At the same time, 10 μg of bait RNA sample was dis-
solved in buffer containing 10 mM HEPES, pH 7.0, 10 mM
MgCl2, and denatured at 65 °C for 5 min and then cooled
to room temperature. SA-PMPs (0.6 mg, Promega) was
rinsed twice with 0.5 × SSC, and then rinsed twice with lysis
buffer. The RNA sample was incubated with the prepared
SA-PMPs at 4 °C for 20 min on a rotating shaker,
then pre-cleared lysates were added and incubated for
another 1.5 h on a rotating shaker. The SA-PMPs was
then washed 3 times with fresh lysis buffer. SDS-loading
buffer (50 μl) was added and the proteins captured were
incubated at 95 °C for 10 min. Samples from each step
were collected for RNA assay.
The proteins were separated by SDS-PAGE and silver
or Coomassie brilliant blue staining, and the gel bands
were excised and in-gel digested with trypsin (0.6 mg), and
the tryptic peptides were subjected to LC-MS/MS analysis
with a LTQ mass spectrometer (ProteomeX-LTQ,
ThermoFisher Scientific). Sequence and peptide finger-
print data were analyzed using the NCBI database.
Expression and purification of recombinant proteins
Open reading frames of different proteins were amplified
from S. aureus NCTC8325 genomic DNA with primers
listed in Table 3. After digested, the PCR product was
ligated into plasmid, then transformed into E. coli DH5α,
and then the expression strains. The plasmids, expression
strains, and conditions for proteins were listed in Tables 2
and 4. The recombinant proteins were purified by
Ni-NTA resin (Qiagen), eluted, passed through an
ultrafiltration system to remove imidazole, and then
stored in 10 % glycerol at -70 °C until use. Protein purity
and concentration were determined by SDS-PAGE and
the BCA assay.
EMSA
EMSA between RNA and RBPs was performed as
previously described [34]. The labeled RNA was denatured
at 65 °C for 10 min and cooled to room temperature.
Increasing amounts of proteins were incubated with RNA
on ice for 30 min in protein buffer. After electrophoresis
in 4 % native polyacrylamide gel in a 1 × TBE buffer, RNAwas electrotransferred to a charged nylon membrane
(Millipore) in 0.5 × TBE. The DIG-labeled RNA was
detected using a DIG gel-shift kit (Roche) according to
the manufacturer’s instructions.
Additional file
Additional file 1: Table S1. List of proteins identified by MS.
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